Need Help? Call 1­-866-­796-­7386
« back to stock screener

  MYGN stock: Myriad Genetics, Inc.

Current Rating
Buy

Previous Rating

Buy
Our Strong Buys
double the S&P500!
Learn more.
Company Statistics
Price
$25.35
Market Cap
3.3B
Sector
Health Care
Div. Growth
-
P/E
260.1
P/B
3.19
P/S
4.15
Dividend %
-
P/CF
-
P/FCF
38.4
Op. Cash Flow
100.1K
FCF
1.2
Op. Margin
2.80%
Net Margin
1.80%
ROE
1.50%
ROI
10.30%
ROA
1.00%
EPS Growth
-88.90%
Current Ratio
3.2
Debt/Equity
1.00%
Company Price P/E Div. Yield Market Cap ($Mil) Rating
DENTSPLY SIRONA Inc (XRAY) $52.33 - 0.70% 12.49B Strong Buy
CVS Health Corp (CVS) $60.28 - 3.60% 71.93B Strong Buy
Bausch Health Companies Inc (BHC) $21.30 - - 8.35B Strong Buy
MTBC Inc (MTBC) $4.75 - - 58.6M Strong Buy
Assertio Therapeutics Inc (ASRT) $1.62 - - 208.7M Strong Buy
Find great stocks now!
Avoid risky stocks
Enter your favorite tickers and click “Get Ratings”

Disclaimer

Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.

All analysis relies on publicly available financial information. Learn More